Weight gain and associated factors in patients using newer antidepressant drugs

dc.contributor.authorUguz, Faruk
dc.contributor.authorSahingoz, Mine
dc.contributor.authorGungor, Buket
dc.contributor.authorAksoy, Fadime
dc.contributor.authorAskin, Rustem
dc.date.accessioned2024-02-23T14:03:00Z
dc.date.available2024-02-23T14:03:00Z
dc.date.issued2015
dc.departmentNEÜen_US
dc.description.abstractObjective: The aim of the present study was to examine weight gain and its association with clinical and sociodemographic characteristics in patients using newer antidepressants. Methods: The study had a cross-sectional design. A total of 362 consecutive psychiatric patients taking antidepressant drugs for 6 to 36 months were included in the study. Results: The prevalence rate of weight gain was 55.2%; 40.6% of the patients had a weight gain of 7% or more compared to the baseline. Overall, antidepressant use was significantly related to increased body weight. Specifically, citalopram, escitalopram, sertraline, paroxetine, venlafaxine, duloxetine and mirtazapine, but not fluoxetine, were associated with significant weight gain. Multivariate logistic regression analysis indicated that lower education status, lower body mass index at the onset of antidepressant use and family history of obesity were independent predictors of weight gain >= 7% compared to the baseline. Conclusions: The study results suggest that patients who take newer antidepressants might have significant problems related to body weight. (C) 2015 Elsevier Inc. All rights reserved.en_US
dc.identifier.doi10.1016/j.genhosppsych.2014.10.011
dc.identifier.endpage48en_US
dc.identifier.issn0163-8343
dc.identifier.issn1873-7714
dc.identifier.issue1en_US
dc.identifier.pmid25467076en_US
dc.identifier.scopus2-s2.0-84922595364en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage46en_US
dc.identifier.urihttps://doi.org/10.1016/j.genhosppsych.2014.10.011
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11935
dc.identifier.volume37en_US
dc.identifier.wosWOS:000348042700011en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofGeneral Hospital Psychiatryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntidepressantsen_US
dc.subjectWeight Gainen_US
dc.subjectBody Mass Indexen_US
dc.titleWeight gain and associated factors in patients using newer antidepressant drugsen_US
dc.typeArticleen_US

Dosyalar